C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a...

Area of Science:

• Gastroenterology
• Clinical Chemistry
• Inflammatory Diseases

Background:

• C-reactive protein (CRP) is a biomarker used in monitoring inflammatory bowel disease (IBD).
• Understanding CRP's relationship with disease characteristics and outcomes is crucial for patient management.
• This study investigates CRP in ulcerative colitis (UC) and Crohn's disease (CD).

Purpose of the Study:

• To determine the association between CRP levels and disease extent in UC.
• To examine the relationship between CRP levels and disease phenotype in CD.
• To evaluate the predictive value of CRP for disease outcomes, specifically surgery risk.

Main Methods:

• CRP levels were measured at diagnosis, 1 year, and 5 years in IBD patients.
• Data from 454 UC and 200 CD patients were analyzed after 5 years.
• Statistical analysis explored correlations between CRP, disease characteristics, and surgical outcomes.

Main Results:

• CD patients exhibited a stronger CRP response compared to UC patients.
• In UC, higher CRP at diagnosis correlated with greater disease extent.
• Elevated CRP levels (e.g., >23 mg/l in extensive UC, >10 mg/l after 1 year in UC, >53 mg/l in CD with L1) predicted increased surgery risk.

Conclusions:

• CRP levels at diagnosis reflect disease extent in UC but not phenotype in CD.
• CRP serves as a valuable predictor of surgical intervention in specific patient subgroups of UC and CD.
• Monitoring CRP levels can aid in identifying IBD patients at higher risk for surgery.